K Number
K181260
Date Cleared
2019-06-21

(406 days)

Product Code
Regulation Number
886.1930
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

MiiS Horus Scope DPT 100 is a digital portable tonometer used to measure intraocular pressure of eyeball.

Device Description

MiiS Horus Scope DPT 100 is a Li-ion battery-powered device. The Li-ion battery is rechargeable. It is a digital portable tonometer used to measure intraocular pressure of eyeball.

The device uses a white LED for illumination and capture image. The device has been tested according to the ISO 15004-2 (first edition, 2/15/2007) and been classified as Group I device.

The device has a CMOS sensor. The sensor accomplishes a task of capturing light and converting it into electrical signals.

The device store images to a SD card and have connectivity towards PC. The device uses an USB 2.0 interface to transfer data or picture to PC when connected.

The operation method of the device is described step by step in the attachment A1 "User manual". There is a graphical user interface color TFT display and keypad that is used for making adjustments before and during measure intraocular pressure of eyeball. Its' measure rang is 7-55 mmHg.

AI/ML Overview

The MiiS Horus Scope DPT 100 is a digital portable tonometer used to measure intraocular pressure of the eyeball. The following information details its acceptance criteria and the study proving its performance.

1. Table of Acceptance Criteria and Reported Device Performance

Performance MetricAcceptance Criteria (from ISO 8612:2009 and ANSI Z80.10-2014)Reported Device Performance (MiiS DPT 100)
Operating RangeNot explicitly stated in the provided text as a numerical range, but implied to be sufficient for clinical use. Predicates have 0-60 mmHg.7-55 mmHg
AccuracyNot explicitly quantified in the provided text, but implied to meet standards.Met the acceptance criteria for accuracy with a manometer-controlled model.
RepeatabilityNot explicitly quantified in the provided text, but implied to meet standards.Met the acceptance criteria for repeatability with a manometer-controlled model.
ReproducibilityNot explicitly quantified in the provided text, but implied to meet standards.Met the acceptance criteria for reproducibility with a manometer-controlled model.
Compliance with Ophthalmic StandardsMeets requirements of ISO 15004-2:2007 (for optical hazards, Group 1 classification).Met all requirements of ISO 15004-2:2007, classified as Group 1 for optical hazards.
BiocompatibilityMeets ISO 10993-5:2009 and ISO 10993-10:2010 standards for contact materials.Met ISO 10993-5:2009 and ISO 10993-10:2010 standards for the chin rest holder material.

Note: The document primarily focuses on overall compliance with standards rather than specific numerical targets for all performance metrics. For "Accuracy," "Repeatability," and "Reproducibility," the text states "The units under test met the acceptance criteria," indicating successful conformance without providing the specific numerical criteria or results.

2. Sample Size Used for the Test Set and Data Provenance

  • Sample Size for Human Eye Clinical Performance Test: The document does not specify the exact number of human subjects or measurements used in the clinical performance test. It only states that "Data was collected" in comparison to the predicate device.
  • Data Provenance: Not explicitly stated. The manufacturer is based in Taiwan (R.O.C.), but the country of origin for the clinical test data is not provided. The study appears to be prospective as it's a "Clinical Performance Test" conducted to evaluate the device against a predicate.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

The document does not mention the use of experts to establish ground truth for the test set. Instead, it relies on a predicate device (Goldmann applanation tonometry (GAT) Keeler Digital Applanation Tonometer (D-KAT) (K133234)) as the comparative standard for the human eye clinical performance test.

4. Adjudication Method

Not applicable. The study compares the device's measurements directly to a predicate device, not against an adjudicated expert consensus.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No, a multi-reader multi-case (MRMC) comparative effectiveness study was not conducted or described. The study focused on the device's technical performance and its direct comparison to a predicate tonometer. There is no mention of human readers or AI assistance.

6. Standalone Performance

Yes, a standalone performance evaluation of the algorithm (or device in general, as it's a tonometer, not specifically an AI algorithm for image interpretation) was conducted. The "bench test" evaluated the operating range, accuracy, repeatability, and reproducibility with a manometer-controlled model. The "Clinical Performance Test" also assessed the device's standalone performance by comparing its measurements to a predicate device on human eyes.

7. Type of Ground Truth Used

  • For bench testing: A manometer-controlled model was used as the ground truth for evaluating operating range, accuracy, repeatability, and reproducibility.
  • For clinical performance testing: Measurements from a Goldmann applanation tonometry (GAT) Keeler Digital Applanation Tonometer (D-KAT) (K133234) served as the comparative standard (ground truth) for human eye measurements. Goldmann Applanation Tonometry (GAT) is widely considered the gold standard for intraocular pressure measurement.

8. Sample Size for the Training Set

Not applicable. The MiiS Horus Scope DPT 100 is presented as a tonometer device for direct measurement of intraocular pressure, not an AI-based system that requires a "training set" in the context of machine learning. The document does not mention any AI components or machine learning models that would necessitate a training set.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no mention of a training set for an AI-based system.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

June 21, 2019

Medimaging Integrated Solution Inc. (MiiS) Chih-Lu Hsu COO 1F, No.7, R&D Rd. II Hsinchu Science Park Hsinchu, 30076 Cn

Re: K181260

Trade/Device Name: MiiS Horus Scope DPT 100 Regulation Number: 21 CFR 886.1930 Regulation Name: Tonometer and accessories Regulatory Class: Class II Product Code: HKX Dated: June 14, 2019 Received: June 17, 2019

Dear Chih-Lu Hsu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidanceregulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-devicesafety/medical-device-reporting-mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally. you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-andconsumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Bradley Cunningham Assistant Director DHT1A: Division of Ophthalmic Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows a logo with a circular target-like design at the top and the text "MiiS" at the bottom. The target consists of concentric circles divided into quadrants, with alternating shades of gray and white. The text "MiiS" is in bold blue font and underlined with a blue line. The entire logo is enclosed within a rounded blue border.

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.

510(k) Number (if known) K181260

Device Name MiiS Horus Scope DPT 100

Indications for Use (Describe)

MiiS Horus Scope DPT 100 is a digital portable tonometer used to measure intraocular pressure of eyeball.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (7/17)

PSC Publishing Services (301) 443-6740

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows a logo with a circular target-like design at the top and the word "MiiS" in blue at the bottom. The target consists of concentric circles alternating between black, white, and shades of gray. The entire logo is enclosed in a rounded blue border.

510(k) Summary

Prepared:April 26, 2018
Submitter/Owner'sName/AddressMedimaging Integrated Solution Inc. (MiiS)1F, No.7, R&D Rd. II, Hsinchu Science Park, Hsinchu, Taiwan30076 (R.O.C.)
Contact Person:Mr. Luu Hsu
Telephone: Fax:+886-3-5798860 Ext: 1700
Email Address:+886-3-5798011luu@miis.com.tw

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image is a logo with a circular design at the top and the text "MiiS" at the bottom. The circular design consists of concentric rings divided into alternating black, white, and gray segments, resembling a target or radar screen. The text "MiiS" is written in a bold, blue font. The entire logo is enclosed within a rounded rectangular border with a blue outline.

Device Identification:

Trade/Device Name MiiS Horus Scope DPT 100 Regulation Number: 21 CFR 886.1930 Regulation Name: Non-Contact Tonometer Regulatory Class: Class II Product Code: HKX

Predicate Device:

K013259 Trade/Device Name: Reichert PT100 Portable (Tonometer) Regulation Number: 21 CFR 886.1930 Regulation Name: Non-Contact Tonometer Regulatory Class: Class II Product Code: HKX

K871335 Trade/Device Name: TOPCON COMPUTERIZED TONOMETER CT-80 Regulation Number: 21 CFR 886.1930 Regulation Name: Tonometer, AC-Powered Regulatory Class: Class II Product Code: HKX

Description of Device:

MiiS Horus Scope DPT 100 is a Li-ion battery-powered device. The Li-ion battery is rechargeable. It is a digital portable tonometer used to measure intraocular pressure of eyeball.

The device uses a white LED for illumination and capture image. The device has been tested according to the ISO 15004-2 (first edition, 2/15/2007) and been classified as Group I device.

The device has a CMOS sensor. The sensor accomplishes a task of capturing light and converting it into electrical signals.

The device store images to a SD card and have connectivity towards PC. The device uses an USB 2.0 interface to transfer data or picture to PC when connected.

The operation method of the device is described step by step in the attachment A1 "User manual". There is a graphical user interface color TFT display and keypad that is used for making adjustments before and during measure intraocular pressure of eyeball. Its' measure rang is 7-55 mmHg.

Indications for Use:

MiiS Horus Scope DPT 100 is a digital portable tonometer used to measure intraocular pressure of eyeball.

Substantial Equivalence Summary

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image is a logo with a circular target-like design at the top and the word "MiiS" in blue at the bottom. The target design consists of concentric circles alternating in shades of gray and black. The word "MiiS" is written in a bold, sans-serif font, and it is underlined. The entire logo is enclosed within a rounded blue border.

NO.ItemsDevicePredicate Device 1PredicateDevice 2Same/DifferenceInterpretation
1SubmitterMedimagingIntegrated SolutionInc.Reichert, Ltd.TopconDifference
ProductNameDigital PortableTonometerPortable Non-Contact TonometerComputerizedTonometerEquivalent
Model NameMiiS Horus ScopeDPT 100PT100CT-80
K NumberK181260K013259K871335
Product codeandClassification21 CFR 886.1930,HKX Class II21 CFR 886.1930,HKX Class II21 CFR886.1930, HKXClass IISame
2Intended useMiiS Horus ScopeDPT 100 is a digitalportable tonometerused to measureintraocular pressureof eyeball.The PT100 is a handheld non contacttonometer intendedto measure theintraocular pressureof the eye.CT-80 is anexact, non-contactintraocularpressuremeasurementthat can be doneby air ejection.Same
3Weight1060g1260g (Measurementhead)18kgDifference
4Dimension111mm x 105mm x193mm254mm x 127mm x205mm272(W)×505(D)×430~458(H)mmDifference
5Contact areanon-contactnon-contactnon-contactSame
6Workingdistance12mm12mm11mmEquivalent
7Measurementrange7-55mmHg0-60mmHg0-60mmHgEquivalent
8MeasurementscalemmHgmmHgmmHgSame
9InspectionWindow3.5" Capacitive LCDtouch panelEyepieceMonitor screenDifference
10InterfaceMini USBUSBRS232CEquivalent
11Power sourceLithium-ionrechargeable batteryLithium-ionrechargeable batteryPower cableconnect to thewall powerEquivalent
12Input voltage100~240 VAC, 50/60Hz100~240 VAC,50/60 HzAC 100, 120,220, 230 and240V; 50/60HzEquivalent

Key technological summaries and differences between the device and the predicate devices:

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image is a logo with a circular target-like design at the top and the word "MiiS" in blue at the bottom. The circular design consists of concentric rings of alternating shades of gray and white, creating a visual effect similar to a bullseye. The word "MiiS" is written in a bold, sans-serif font, with a horizontal line underneath it. The entire logo is enclosed within a rounded square with a blue border.

Image /page/6/Picture/2 description: The image shows three different medical devices used for eye examinations. The first device has a square screen and a handle on the side. The second device is handheld and has a display screen on top. The third device is a larger, stationary machine with a screen and a joystick.

Substantial Equivalence Discussion

Similarities:

  • MiiS Horus scope DPT 100 and predicate device, Reichert PT100 Portable (Tonometer) have the same intended use. Both devices have same specifications, such as contact area, working distance, power source and input voltage. DPT 100 has similar specifications to Reichert PT100 Portable (Tonometer), such as the measurement range, measurement scale, weight, dimension and connection interface.
  • -MiiS Horus scope DPT 100 and predicate device, Topcon CT-80 Computerized Tonometer have the same intended use. DPT 100 has similar specifications to Topcon CT-80 Computerized Tonometer, such as the working distance, measurement range, measurement scale and input voltage.

Differences:

  • The major differences are inspection window. MiiS Horus scope DPT 100 has 3.5" -Capacitive LCD touch panel. But, Reichert, Ltd. PT100 use eyepiece to observe.
  • -The major differences between MiiS Horus scope DPT 100 and Topcon CT-80 Computerized Tonometer are weight, dimension, inspection window, interface, power source and product appearance.
  • -These variants don't impact on device safety and effectiveness.

Non-clinical and Clinical Tests

The following data were provided in support of the substantial equivalence determination:

    1. EMC and electrical safety testing were conducted on the DPT 100. The device complies with IEC/EN 60601-1-2:2014/2015 for EMC and IEC/EN 60601-1:2005/2006+A1:2012/ 2013 for Safety.
    1. Software verification and validation testing was done according to IEC 62304.
    1. Risk management: DPT 100 was evaluated according to ISO 14971:2007 and EN ISO 14971:2012. All risks have been reduced to safe levels thus there is no conflict between risk and benefit.
    1. Tests for ophthalmic products: DPT 100 was tested in accordance with ISO 15004-2:2007 standards and was found to meet all requirements of the standards. For optical hazards was classified to Group 1.

{7}------------------------------------------------

Image /page/7/Picture/0 description: The image shows a logo with a circular target-like design at the top and the word "MiiS" in blue at the bottom. The target design consists of concentric circles alternating between black, white, and gray shades. The word "MiiS" is written in a bold, sans-serif font and is underlined with a blue line. The entire logo is enclosed within a rounded rectangle with a white background.

    1. Biocompatibility: The contact part to patient is the holder of chin rest CR100. The holder material was tested in accordance with ISO10993-5:2009 and ISO10993-10:2010 standards.
    1. Tests for tonometer:

The performance of MiiS DPT 100 has been evaluated in bench test. The units under test met the acceptance criteria of the operating range, accuracy, repeatability and reproducibility with a manometer-controlled model. We also do Clinical Performance Test, and found a Goldmann applanation tonometry (GAT) Keeler Digital Applanation Tonometer (D-KAT) (K133234) to do the human eye Clinical performance test compared to MiiS DPT 100. Data was collected according to ISO 8612:2009 and ANSI Z80.10-2014 "Ophthalmic Instruments – Tonometers" (in accordance with FDA's extent of recognition) with the following results.

Conclusion

Substantial equivalence comparison and bench performance tests support the conclusion of substantial equivalence of MiiS Horus scope DPT 100 to the predicate devices.

§ 886.1930 Tonometer and accessories.

(a)
Identification. A tonometer and accessories is a manual device intended to measure intraocular pressure by applying a known force on the globe of the eye and measuring the amount of indentation produced (Schiotz type) or to measure intraocular tension by applanation (applying a small flat disk to the cornea). Accessories for the device may include a tonometer calibrator or a tonograph recording system. The device is intended for use in the diagnosis of glaucoma.(b)
Classification. Class II.